Recursive cumulative meta-analysis: A diagnostic for the evolution of total randomized evidence from group and individual patient data

被引:64
作者
Ioannidis, JPA
Contopoulos-Ioannidis, DG
Lau, J
机构
[1] NIAID, Therapeut Res Program, Div AIDS, NIH, Bethesda, MD 20892 USA
[2] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA
[3] Tufts Univ, Sch Med, Div Clin Care Res, New England Med Ctr Hosp, Boston, MA 02111 USA
关键词
meta analysis; randomized trials; bias; study design; publication bias;
D O I
10.1016/S0895-4356(98)00159-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Meta-analyses of randomized evidence may include published, unpublished, and updated data in an ongoing estimation process that continuously accommodates more data. Synthesis may be performed either with group data or with meta-analysis of individual patient data (MIPD). Although MIPD with updated data is considered the gold standard of evidence, there is a need for a careful study of the impact different sources of data have on a meta-analysis and of the change in the treatment effect estimates over sequential information steps. Unpublished data and late-appearing data may be different from early-appearing data. Updated information after the end of the main study follow-up may be affected by cross-overs, missing information, and unblinding. The estimated treatment effect may thus depend on the completeness and updating of the available evidence. To address these issues, we present recursive cumulative meta-analysis (RCM) as an extension of cumulative metaanalysis. Recursive cumulative meta-analysis is based on the principle of recalculating the results of a cumulative meta-analysis with each new or updated piece of information and focuses on the evolution of the treatment effect as a more complete and updated picture of the evidence becomes available. An examination of the perturbations of the cumulative treatment effect over sequential information steps may signal the presence of bias or heterogeneity in a meta-analysis. Recursive cumulative meta-analysis may suggest whether then is a true underlying treatment effect to which the meta-analysis is converging and how treatment effects are sequentially altered by new or modified evidence. The method is illustrated with an example from the conduct of an MIPD on acyclovir in human immunodeficiency virus infection. The relative strengths and limitations of both meta analysis of group data and MIPD are discussed through the RCM perspective. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:281 / 291
页数:11
相关论文
共 51 条
  • [1] Uncertainty of the time of first significance in random effects cumulative meta-analysis
    Berkey, CS
    Mosteller, F
    Lau, J
    Antman, EM
    [J]. CONTROLLED CLINICAL TRIALS, 1996, 17 (05): : 357 - 371
  • [2] THE COCHRANE COLLABORATION - PREPARING, MAINTAINING, AND DISSEMINATING SYSTEMATIC REVIEWS OF THE EFFECTS OF HEALTH-CARE
    BERO, L
    RENNIE, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (24): : 1935 - 1938
  • [3] DISCORDANCE BETWEEN METAANALYSES AND LARGE-SCALE RANDOMIZED, CONTROLLED TRIALS - EXAMPLES FROM THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION
    BORZAK, S
    RIDKER, PM
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) : 873 - 877
  • [4] Large trials vs meta-analysis of smaller trials - How do their results compare?
    Cappelleri, JC
    Ioannidis, JPA
    Schmid, CH
    deFerranti, SD
    Aubert, M
    Chalmers, TC
    Lau, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1332 - 1338
  • [5] CHAVANET P, 1990, CANCER DETECT PREV, V14, P669
  • [6] Collier AC, 1998, ANTIVIR THER, V3, P25
  • [7] A PILOT-STUDY OF LOW-DOSE ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    COLLIER, AC
    BOZZETTE, S
    COOMBS, RW
    CAUSEY, DM
    SCHOENFELD, DA
    SPECTOR, SA
    PETTINELLI, CB
    DAVIES, G
    RICHMAN, DD
    LEEDOM, JM
    KIDD, P
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) : 1015 - 1021
  • [8] COLLIER AC, 1995, 2 NAT C HUM RETR REL
  • [9] COLLINS R, 1995, LANCET, V345, P669
  • [10] THE EFFICACY AND SAFETY OF ZIDOVUDINE ALONE OR AS COTHERAPY WITH ACYCLOVIR FOR THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, RANDOMIZED TRIAL
    COOPER, DA
    PEHRSON, PO
    PEDERSEN, C
    MORONI, M
    OKSENHENDLER, E
    ROZENBAUM, W
    CLUMECK, N
    FABER, V
    STILLE, W
    HIRSCHEL, B
    FARTHING, C
    DOHERTY, R
    YEO, JM
    [J]. AIDS, 1993, 7 (02) : 197 - 207